KYNB Kyntra Bio, Inc.

NASDAQ
$3.44

Kyntra Bio, Inc. (KYNB) Earnings News

Earnings press releases, previews and reviews for Kyntra Bio, Inc. (KYNB), newest first. Our most recent is preview: Kyntra Bio Heads Into Q3 With Stock Halved and a Prostate Cancer Interim Readout Looming.